<code id='091B938918'></code><style id='091B938918'></style>
    • <acronym id='091B938918'></acronym>
      <center id='091B938918'><center id='091B938918'><tfoot id='091B938918'></tfoot></center><abbr id='091B938918'><dir id='091B938918'><tfoot id='091B938918'></tfoot><noframes id='091B938918'>

    • <optgroup id='091B938918'><strike id='091B938918'><sup id='091B938918'></sup></strike><code id='091B938918'></code></optgroup>
        1. <b id='091B938918'><label id='091B938918'><select id='091B938918'><dt id='091B938918'><span id='091B938918'></span></dt></select></label></b><u id='091B938918'></u>
          <i id='091B938918'><strike id='091B938918'><tt id='091B938918'><pre id='091B938918'></pre></tt></strike></i>

          explore

          explore

          author:Wikipedia    Page View:19
          Richard Burr
          North Carolina Senator Richard Burr received strong support from the biotech sector. Gerry Broome/AP

          WASHINGTON — A veteran senator and champion of the biotech sector beat back an unusually strong challenge Tuesday night — thanks in large part to loyal support from the industry.

          North Carolina Senator Richard Burr, a Republican who has long protected the bioscience companies that drive his state’s economy, overcame a surprisingly robust challenge from Democratic candidate Deborah K. Ross.

          advertisement

          Burr, now finishing his second term in the Senate, serves on committees with oversight of both the Food and Drug Administration and Medicare and Medicaid. He is also chairman of the Select Committee on Intelligence.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          leisure time

          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more
          STAT Summit: GSK CEO on pharma giant's new direction
          STAT Summit: GSK CEO on pharma giant's new direction

          GSKCEOEmmaWalmsleyatthe2023STATSummit.STATThestoryofGSKisoneofreinvention,CEOEmmaWalmsleysaidattheST

          read more
          After affirmative action ruling, medical educators look to 'holistic review'
          After affirmative action ruling, medical educators look to 'holistic review'

          AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

          read more

          CDC advisory group OKs chikungunya vaccine

          RickBowmer/APInaglobalfirst,sometravelersandlaboratoryresearcherswhoareatriskofcontractingchikunguny